Literature DB >> 7695410

Second primary lung cancer.

T Antakli1, R F Schaefer, J E Rutherford, R C Read.   

Abstract

We reviewed our experience with second primary lung cancer (SPLC) at the Little Rock Veterans Affairs Medical Center from 1966 to 1993. Fifty-four patients were found to have 65 such lesions after 1,572 "curative" resections for lung cancer (4.1%). Eleven patients had at least a third primary tumor (3 having more). Metachronous SPLCs comprised 60% (39/65) and synchronous 40% (26/65). The mean interval between first and second tumors was 54.63 +/- 8 (standard error) months (range, 5 to 218 months), and that between second and third was 26.1 +/- 7.4 (standard error) (range, 5.5 to 51 months). Squamous cell carcinoma comprised 58.4% (38/65), adenocarcinoma 30.8% (20/65), and small cell carcinoma 10.8% (7/65). Histology of the SPLC was the same as that of the first tumor in 50.7% (33/65). Stage I primary tumors comprised 76% (41/54) of index tumors, 61.1% (33/54) of SPLCs, and 72.2% (8/11) of third primary tumors. Second primary lung cancer followed minimal resection in 44% (24/54), lobectomy in 37% (20/54), and pneumonectomy in 13% (7/54) of cases. There was no evidence that minimal resection for the first primary tumor predisposed to SPLC. After 1983 the majority of SPLCs were diagnosed with computed tomographic scanning. After resection of SPLCs, survival rates at 3 and 5 years were 26% and 18%, metachronous 39% and 23.4%, and synchronous 12.25% and 12.25%.

Entities:  

Mesh:

Year:  1995        PMID: 7695410     DOI: 10.1016/0003-4975(95)00067-u

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  45 in total

1.  Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.

Authors:  W A Franklin; A F Gazdar; J Haney; I I Wistuba; F G La Rosa; T Kennedy; D M Ritchey; Y E Miller
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Surveillance and the second primary lung cancer: Enhancing our understanding beyond Martini and Melamed.

Authors:  Melanie P Subramanian; Varun Puri
Journal:  J Thorac Cardiovasc Surg       Date:  2018-10-26       Impact factor: 5.209

Review 3.  Management pathways for solitary pulmonary nodules.

Authors:  Masaoki Ito; Yoshihiro Miyata; Morihito Okada
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

4.  Clinical features of multiple lung cancers based on thin-section computed tomography: what are the appropriate surgical strategies for second lung cancers?

Authors:  Aritoshi Hattori; Kenji Suzuki; Kazuya Takamochi; Shiaki Oh
Journal:  Surg Today       Date:  2014-05-22       Impact factor: 2.549

5.  Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.

Authors:  Martin Faehling; Birgit Schwenk; Sebastian Kramberg; Sabine Fallscheer; Matthias Leschke; Jörn Sträter; Robert Eckert
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-30       Impact factor: 4.553

6.  Risk-adjusted cancer-incidence rates (United States).

Authors:  R M Merrill; E J Feuer
Journal:  Cancer Causes Control       Date:  1996-09       Impact factor: 2.506

7.  Adjuvant vinorelbine and cisplatin after complete resection of stage II and III non-small cell lung cancer: long-term follow-up of our study of Japanese patients.

Authors:  Makoto Sonobe; Masatsugu Hamaji; Hideki Motoyama; Toshi Menju; Akihiro Aoyama; Toyofumi F Chen-Yoshikawa; Toshihiko Sato; Hiroshi Date
Journal:  Surg Today       Date:  2018-03-03       Impact factor: 2.549

8.  Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis.

Authors:  A Casutt; H Bouchaab; C Beigelman-Aubry; J Bourhis; A Lovis; O Matzinger
Journal:  Br J Radiol       Date:  2015-03-04       Impact factor: 3.039

9.  Synchronous double primary lung cancers via p53 pathway induced by heavy smoking.

Authors:  Cheng-Chih Lin; Chih-Feng Chian; Wann-Cherng Perng; Ming-Fang Cheng
Journal:  Ann Saudi Med       Date:  2010 May-Jun       Impact factor: 1.526

10.  Surgical treatment of synchronous multiple primary lung cancers: a retrospective analysis of 122 patients.

Authors:  Ming Liu; Wenxin He; Jie Yang; Gening Jiang
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.